Usefulness and limits of intraoperative hormone measurements in surgery of endocrine duodeno-pancreatic tumors: Experience of 72 cases;Utilite et limites des dosages hormonaux peroperatoires dans la chirurgie des tumeurs endocrines duodeno-pancreatiques: Experience de 72 cas

Annales de Biologie Clinique

Volumn 57, Issue 2, 1999, Pages 185-190

  D'Herbomez, M ^a   Pattou, F ^a   Nocaudie, M ^a   Carnaille, B ^a   Proye, C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Gastrin; Insulimomas; Insulin; Intraoperative measurement; Zollinger Ellison

Indexed keywords

GASTRIN; INSULIN; MONOCLONAL ANTIBODY; SECRETIN; PROINSULIN; TUMOR MARKER;

ARTICLE; DUODENUM TUMOR; GASTRIN BLOOD LEVEL; GASTRINOMA; HORMONE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULINOMA; MAJOR CLINICAL STUDY; METHODOLOGY; PANCREAS TUMOR; PORTAL VEIN BLOOD; PROGNOSIS; BLOOD; CHEMISTRY; GLUCOSE BLOOD LEVEL; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATIENT CARE PLANNING; PEROPERATIVE CARE; PORTAL VEIN; STOMACH ACID; ZOLLINGER ELLISON SYNDROME;

BLOOD GLUCOSE; DUODENAL NEOPLASMS; GASTRIC ACID; GASTRINOMA; GASTRINS; HUMANS; HYPOGLYCEMIA; INSULIN; INSULINOMA; INTRAOPERATIVE CARE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATIENT CARE PLANNING; PORTAL VEIN; PROINSULIN; SECRETIN; TUMOR MARKERS, BIOLOGICAL; ZOLLINGER-ELLISON SYNDROME;

EID: 0033091774     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bertherat J, Mourrieras F, Thomopoulos P, Luton JP, Roseau JP, Pitre J. Les hypoglycémies organiques. Le point à l'aube du troisième millénaire. Rev Franç Endocrinol Clin 1997 ; 38 : 4-5 ; 143-63.
2. Van Boxsom P, Peix JL, Cougard P, et al. Les insulinomes pancréatiques dans la néoplasie endocrinienne multiple de type I. Rev Franc End Clin 1995 ; 36 : 105-18.
3. O'Rior Dain DS, O'Brien T, Van Heerden JA, Service FJ, Grant CS. Surgical management of insulinoma associated with multiple neoplasia type I. World J Surg 1994 ; 18 : 488-94.
4. Mignon M, Lamarthe B, Cadiot G, Zollinger-Ellison. Syndrome. Rev Prat 1994 ; 44 : 1620-8.
5. Jensen RT. Gastrointestinal endocrine tumours. Gastrinoma. Clin Gastroenterol 1996 ; 10 : 603-43.
6. Hirschowitz BI, Zollinger-Ellison syndrome : pathogenesis, diagnosis and management. Am J Gastroenterol 1997 ; 92 : 445-508.
7. Chanson P, Cadiot G, Murat A. Management of patients and subjects at risk for multiple endocrine neoplasic type 1 : MEN1. GENEM1. Groupe d'étude des néoplasies endocriniennes multiples de type I. Horm Res 47 : 4-6 : 24-30.
8. Termanini B, Gibrel F, Reynolds JC, Doppman JL, Chen CC, Stewart CA. Value of somatostatin receptor scintigraphy : a prospective study in gastrinoma of its effects on clinical managment. Gastroenterology 1997 ; 112 : 335-47.
9. Lebthahi R, Cadiot G, Sarda L, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997 ; 38 : 853-8.
10. Doppman JL, Miller DL, Chang R, Gorden P, Eastman RC, Norton JA. Intra-arterial calcium stimulation test for detection of insulinomas. World J Surg 1993 ; 17 : 439-43.
11. Imamura M, Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J Surg 1993 ; 17 : 433-7.
12. Parneix M, Rullier E, Gin H, Roche A. Apport du pancréas artificiel dans le diagnostic et dans le traitement chirurgical des insulinomes. Ann Chir 1994 ; 48 : 421-9.
13. Proye C. Surgical strategy in insulinomas in adults. Acta Chir Scand 1987 ; 153 : 481-91.
14. Proye C, et al. Tumeurs endocrines du pancréas. Éditions techniques. Encyclopédie Médico-Chirurgicale Paris 1995, p 49.
15. Proye C, Fulla Y, Fourlinnie JC, Cecat P, Vergnes R. Chirurgie des tumeurs pancréatiques hypoglycémiantes. Intérêt des dosages peropératoires de l'insulinémie portale. Lille Chir 1982 ; 37 : 79-83.
16. Rothmund M, Angelini L, Brunt LM, et al. Surgery for benign insulinoma : an international review. World J Surg 1990 ; 14 : 393-9.
17. Rabkin R, Simmons RE. Renal metabolism of hormones. In : Principles and practice of endocrinology and metabolism. K.L. Becker Ed Lippincott, Philadelphia ? ; 1523-9.
18. Csorba T. Proinsulin : biosynthesis, conversion assay methods and clinical studies. Clin Biochem 1991 ; 24 : 447-54.
19. Gallow JA, Hopper SA, Spradlin CT, et al. Biosynthetic human proinsulin. Diabetes Care 1992 ; 15 : 666-92.
20. Gorden P, Skarulis MC, Roach P, et al. Plasma pro-insulin like composent in Insulinoma : a 25 years experience. J Clin Endocrinol Metab 1995 ; 80 : 2884-5.
21. Growthers NJ, Gray IP. Immunometric assay of insulin and its precursors. J Clin Ligand Assay 1996 ; 19 : 112-20.
22. Hampton SM, Beyzavi K, Teale D, Marks V. A direct assay for proinsulin in plasma and its application in hypoglycemia. Clin Endocrinol 1988 ; 29 : 9-16.
23. Kao PC, Taylor RL, Service FJ. Proinsulin by immunochemilumino-metric assay for the diagnosis of insulinoma. J Clin Endocrinol Metab 1994 ; 78 : 1048-51.
24. Tasaka J, Nakaya F, Matsumoto H, Odagiri R, Ohgawara H, Omori Y. Tumor and serum levels of proinsulin and insulin in insulinoma patients. Endoc Journ 1993 ; 40 : 245-8.
25. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales NG. Radioimmunoassay may overestimate insulin in non-insulin dependant diabetics. Clin Endocrinol 1990 ; 32 : 689-93.
26. Chevenne D, Letailleur A, Trivin F, Porquet D. Dosage des proinsulines, insuline et peptide C plasmatiques. Ann Biol Clin 1995 ; 53 : 3-9.
27. O'Rahilly S, Burnett MA, Smith RJ, Darley JH, Turner RC. Haemolysis affects insulin hut not C-peptide immunoassay. Diabetologia 1987 ; 30 : 394-6.
28. Sapin R, Gasser F, Grucker D. Prevention des effets de l'hémolyse sur le dosage d'insuline. Immunol Biol Spéc 1997 ; 12 : 206-8.
29. Sazic T, Seitz MJ, Pavelic K. Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artefact caused by insulin tracer degradation : involvement of the insulin-degrading enzyme. Mol Cell Endocrinol 1994 ; 106 : 23-9.
30. Berman N, Genter P, Chau HF, Cortez C, Bowsher R, Ipp E. Erratic oscillatory characteristics of plasma insulin concentrations in patients with insulinoma : mechanism for unpredictable hypoglycemia. J Clin Endocrinol Metab 1997 ; 82 : 2899-903.
31. Robertson GS, Lake SP, Iqbal SJ, Veitch PS, Boha A. Serum gastrin levels in the pre-operative localization and surgical treatment of gastrinomas. JR Coll Surg Edimb 1995 ; 40 : 225-9.